Learn more

MA HAILONG

Overview
  • Total Patents
    32
  • GoodIP Patent Rank
    53,538
About

MA HAILONG has a total of 32 patent applications. Its first patent ever was published in 2005. It filed its patents most often in China. Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are BEIJING BIOHEALTHCARE BIOTECHNOLOGY CO LTD, GEMSTAR CAMBRIDGE LTD and BIOCENTURY TRANSGENE (CHINA) CO LTD.

Patent filings in countries

World map showing MA HAILONGs patent filings in countries
# Country Total Patents
#1 China 32

Patent filings per year

Chart showing MA HAILONGs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Ma Hailong 32
#2 Yin Hao 1
#3 Wang Qun 1

Latest patents

Publication Filing date Title
CN109409975A Block chain merchandise storage device, block chain commodity storage system, recording device and block chain management system
CN106440400A Solar smelting device and system
CN104650198A Active peptides separated from Sphacelaria furcigera Kuetz capable of treating diabetes and application thereof
CN104402990A Polypeptide for treating diabetes
CN105732803A Aptamer NKXA6 specifically aiming at Neutrokine-alpha protein and application thereof
CN105732801A Aptamer NKXA13 specifically aiming at Neutrokine-alpha protein and application thereof
CN105732800A Aptamer NKXA15 specifically aiming at Neutrokine-alpha protein and application thereof
CN105732802A Aptamer NKXA11 specifically aiming at Neutrokine-alpha protein and application thereof
CN104177488A Specific nucleic acid aptamer for Neutrokine-alpha protein and application thereof
CN105732799A Aptamer NKXA18 specifically aiming at Neutrokine-alpha protein and application thereof
CN105693846A Aptamer NKXA10 specifically for Neutrokine-alpha protein and application of aptamer NKXA10
CN105693849A Aptamer NKXA5 specifically for Neutrokine-alpha protein and application of aptamer NKXA5
CN105713083A Specific aptamer NKXA17 for Neutrokine-alpha protein and application of specific aptamer NKXA17
CN105693847A Aptamer NKXA9 specifically for Neutrokine-alpha protein and application of aptamer NKXA9
CN105693848A Aptamer NKXA7 specifically for Neutrokine-alpha protein and application of aptamer NKXA7
CN105753967A Nucleic acid aptamer NKXA14 specifically aiming at Neutrokine-alpha protein and application thereof
CN105732804A Aptamer NKXA4 specifically aiming at Neutrokine-alpha protein and application thereof
CN104672305A Anti-tumor peptide variant NC11 and application thereof
CN104610429A Anti-tumor peptide variant NC13 and application thereof
CN104130311A Antitumor peptide variant and application thereof